Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 17Recruiting 5Active not recruiting 4Withdrawn 3Terminated 3Not yet recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Lymphoma 1Leukemia 1Carcinoma, Pancreatic Ductal 1Burkitt Lymphoma 1

Interventions

Bevacizumab 14Injections 13Drug Therapy 10Gemcitabine 9toripalimab 8venetoclax 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Cyclophosphamide 7Carboplatin 7pembrolizumab 6irinotecan sucrosofate 6Temozolomide 6HMPL-013 6tislelizumab 5sintilimab 5fludarabine 5N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5Fluorouracil 5Etoposide 5Cisplatin 5Biopsy 5osimertinib 4lenvatinib 4Rituximab 4Radiotherapy 4Pemetrexed 4Paclitaxel 4Oxaliplatin 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Immunotherapy, Adoptive × Clear all
NCT07153289 2025-09-03

ResCPa

University Hospital Tuebingen

Phase 1/2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT07020260 2025-06-13

PACMAN

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Not yet recruiting
18 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡